Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer - Related Studies

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

This study is ongoing, but not recruiting participants.

Study NCT00004879. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Cancer
		Esophageal Cancer
		Kidney Cancer
		Lung Cancer
		Pancreatic Cancer
		Prostate Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Renal Cell
		Colorectal Neoplasms
		Esophageal Diseases
		Esophageal Neoplasms
		Kidney Neoplasms
		Lung Neoplasms
		Pancreatic Neoplasms
		Prostatic Neoplasms

3	More general conditions related to this trial
		Adenocarcinoma
		Carcinoma
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Genital Diseases, Male
		Genital Neoplasms, Male
		Head and Neck Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Kidney Diseases
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Pancreatic Diseases
		Prostatic Diseases
		Rectal Diseases
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms
		Urogenital Neoplasms
		Urologic Diseases
		Urologic Neoplasms

4	Interventions listed in this trial
		panitumumab

5	Sponsors listed in this trial
		Jonsson Comprehensive Cancer Center
		National Cancer Institute (NCI)